Vivo Capital, LLC Q4 2024 Filing
Filed February 13, 2025
Portfolio Value
$892.6B
Holdings
40
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (40 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SLNOSoleno Therapeutics Inc | 6,291,851 | $282.8B | 31.68% | |
| 2 | VRNAVerona Pharma PLC | 2,283,975 | $106.1B | 11.88% | |
| 3 | GONGeron Corp | 27,225,292 | $96.4B | 10.80% | |
| 4 | TERNTerns Pharmaceuticals Inc | 6,895,746 | $38.2B | 4.28% | |
| 5 | AVDLAvadel Pharmaceuticals PLC | 2,684,109 | $28.2B | 3.16% | |
| 6 | DYNDyne Therapeutics Inc | 1,114,960 | $26.3B | 2.94% | |
| 7 | ACRSAclaris Therapeutics, Inc. | 8,888,888 | $22.0B | 2.47% | |
| 8 | DCTHDelcath Systems, Inc. | 1,708,579 | $20.6B | 2.30% | |
| 9 | VRDNViridian Therapeutics Inc | 982,576 | $18.8B | 2.11% | |
| 10 | CDTXCidara Therapeutics, Inc. | 670,600 | $18.0B | 2.02% | |
| 11 | ERASErasca Inc | 6,756,756 | $17.0B | 1.90% | |
| 12 | TRVITrevi Therapeutics Inc | 3,487,903 | $14.4B | 1.61% | |
| 13 | CATBUSDAstria Therapeutics Inc | 1,552,685 | $13.9B | 1.56% | |
| 14 | RZLTRezolute Inc | 2,797,704 | $13.7B | 1.54% | |
| 15 | SERASera Prognostics Inc | 1,650,440 | $13.4B | 1.51% | |
| 16 | TRMLTourmaline Bio Inc. | 591,882 | $12.0B | 1.34% | |
| 17 | CRVSCorvus Pharmaceuticals Holdings | 2,234,566 | $12.0B | 1.34% | |
| 18 | TILInstil Bio Inc | 585,485 | $11.2B | 1.25% | |
| 19 | ORICOric Pharmaceuticals Inc | 1,277,818 | $10.3B | 1.16% | |
| 20 | ABEOAbeona Therapeutics, Inc. | 1,842,751 | $10.3B | 1.15% | |
| 21 | ZBIOZenas Biopharma Inc | 1,183,260 | $9.7B | 1.09% | |
| 22 | DRUGBright Minds Biosciences Inc | 251,572 | $9.1B | 1.02% | |
| 23 | OLMAOlema Pharmaceuticals Inc | 1,505,862 | $8.8B | 0.98% | |
| 24 | COGTCogent Biosciences Inc | 1,122,471 | $8.8B | 0.98% | |
| 25 | CELCCelcuity Inc | 610,500 | $8.0B | 0.90% | |
| 26 | VSTMVerastem Inc | 1,538,461 | $8.0B | 0.89% | |
| 27 | UNCYUnicycive Therapeutics | 9,970,152 | $7.9B | 0.89% | |
| 28 | RGLSRegulus Therapeutics Inc | 5,000,000 | $7.9B | 0.89% | |
| 29 | SLNSilence Therapeutics PLC | 1,105,454 | $7.6B | 0.85% | |
| 30 | CMPSCompass Pathway PLC | 1,608,000 | $6.1B | 0.68% | |
| 31 | IOBTIO Biotech Inc | 6,173,439 | $5.7B | 0.64% | |
| 32 | ALGSAligos Therapeutics Inc | 141,879 | $5.7B | 0.63% | |
| 33 | CMPXCompass Therapeutics Inc | 3,556,023 | $5.2B | 0.58% | |
| 34 | ALLKGUSDAllakos Inc | 2,956,110 | $3.6B | 0.40% | |
| 35 | CRBPCorbus Pharmaceuticals Holdings | 166,794 | $2.0B | 0.22% | |
| 36 | BOLT1EURBolt Therapeutics Inc | 3,521,291 | $1.9B | 0.21% | |
| 37 | TENXTenax Therapeutics Inc | 208,333 | $1.3B | 0.14% | |
| 38 | DBVTDBV Technologies SA | 32,020 | $98.9M | 0.01% | |
| 39 | QTTBQ32 Bio Inc. | 20,559 | $70.7M | 0.01% | |
| 40 | DTILPrecision Biosciences Inc | 4,675 | $17.8M | 0.00% |